Show notes
This episode is brought to you by Semafor Healthcare.
Delivered weekly from David Lim, Semafor Healthcare connects the dots between decisions in government, business, and technology to reveal how they impact the future of healthcare. Each edition will provide the analysis you need to understand and stay ahead of a rapidly changing landscape. Subscribe for free.
This episode was originally published on July 19, 2022.
It's well known that the United States spends much more than other high-income countries on health care, the most recent estimates from the Centers for Medicare and Medicaid Services published in Health Affairs show that nearly a fifth of US GDP is spent on health care services.
It's perhaps somewhat less well known that health outcomes lag those of many other countries. Life expectancy and infant mortality rates rank well below not just other high-income countries, but many middle-income countries as well.
The combination of these two facts leads many to ask the question, "Are we getting our money's worth for all that we spend on health care?"
However, simply establishing that the US spends a lot on health care and has sub-optimal health outcomes doesn't fully answer the question.
Marcia Weaver from the University of Washington joins A Health Podyssey to discuss whether we receive value for our high levels of health spending.
Weaver and coauthors published a paper in the July 2022 of Health Affairs examining the relationship between health spending and disease burden in the United States. They reached some optimistic conclusions based on the data.
Order the July 2022 issue of Health Affairs for research on Type 2 diabetes and more.
Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcasts free for everyone.
Subscribe: RSS | Apple Podcasts | Spotify | Stitcher | Google Podcasts
Subscribe to Semafor Healthcare for free.
Our TOPPODCAST Picks 
Stay Connected
